Premium Heparin Sodium API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Heparin Sodium (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Anticoagulant (Unfractionated Glycosaminoglycan)

Indications: Prophylaxis and treatment of venous thromboembolism, cardiovascular surgery, and catheter lock flush solutions

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Heparin Sodium distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Heparin Sodium is a highly sulfated, naturally occurring glycosaminoglycan. In cardiovascular and hematological pharmacology, it functions as a critical unfractionated anticoagulant. Unlike chemically synthesized small molecules, Heparin Sodium is a biological Active Pharmaceutical Ingredient (API), predominantly extracted and purified from porcine intestinal mucosa.

At the physiological level, Heparin Sodium does not dissolve existing clots but prevents the extension of existing thrombi and the formation of new ones. It acts as a catalyst by binding reversibly to antithrombin III (ATIII). This binding induces a conformational change in ATIII that accelerates its ability to inactivate several coagulation enzymes—most notably thrombin (Factor IIa) and Factor Xa. By blocking the conversion of fibrinogen to fibrin, the API halts the coagulation cascade.

For formulation scientists, this biological API is indispensable for developing critical-care parenteral therapeutics. In commercial manufacturing, it is typically formulated into intravenous (IV) infusions, deep subcutaneous injections, and low-dose lock flush solutions utilized to maintain the patency of indwelling intravenous catheters.

Sourcing Heparin Sodium in Pakistan: Morgan’s Supply Network

Developing parenteral anticoagulants requires a highly scrutinized and fully traceable raw material pipeline. Because Heparin is a biologically derived product, procurement demands rigorous oversight to prevent contamination (such as oversulfated chondroitin sulfate, or OSCS) and ensure viral clearance. Sourcing Heparin Sodium Pakistan through Morgan’s localized distribution network mitigates these critical supply chain and compliance risks.

Morgan sources commercial-scale and pilot-scale quantities from vetted global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive viral clearance data, OSCS absence certification, and stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: The global biological API market is prone to severe fluctuations. Our localized inventory management eliminates international transit variables. Whether you require standard batches or are scaling up a high-volume Heparin Sodium api Pakistan procurement order, we ensure your commercial batch schedules and production timelines are met without raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent biological potency (measured in International Units), stringent endotoxin limits, and physical uniformity for predictable behavior during sterile compounding.

Technical Specifications for QA & R&D

The Heparin Sodium API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards (USP/EP).

• Chemical Name: Heparin, sodium salt
• CAS Number: 9041-08-1
• Source Origin: Porcine intestinal mucosa (strictly traceable supply chain)
• Appearance: White or almost white, moderately hygroscopic powder
• Potency / Biological Activity: Expressed in IU/mg (specific potency minimums, e.g., ≥ 180 IU/mg, are detailed in the batch CoA compliant with current USP/EP monographs)
• Solubility Profile: Freely soluble in water. Detailed solubility parameters and pH limits for aqueous solutions (typically 5.5 to 8.0 for a 1% w/v solution) are documented in the technical data sheet to assist analytical R&D teams with parenteral vehicle formulation.

Manufacturing and Handling Guidelines for Formulators

Heparin Sodium is a potent biological anticoagulant intended for sterile injectable formulations. Facilities processing this API must enforce strict environmental controls and occupational exposure limits (OEL).

• Storage Conditions: Because the powder is highly hygroscopic, the raw API must be stored in airtight, securely closed containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from ambient humidity and excessive heat) to prevent moisture uptake and degradation of biological activity.
• Occupational Safety and Sterility: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including industrial dust masks, chemical-resistant nitrile gloves, and full protective facility garments. Because the end product is parenteral, dispensing and compounding stages must be executed within highly controlled, classified cleanrooms (ISO 5/Class A laminar flow hoods) to maintain strict bioburden and bacterial endotoxin limits prior to terminal sterilization or sterile filtration.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.